Integrated Biopharma Volatility
| INBPDelisted Stock | USD 0.33 0.00 0.00% |
We have found twenty-one technical indicators for Integrated Biopharma, which you can use to evaluate the volatility of the firm. Please check out Integrated Biopharma's Standard Deviation of 4.05, market risk adjusted performance of 0.4707, and Risk Adjusted Performance of (0.02) to validate if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Integrated Biopharma's volatility include:
360 Days Market Risk | Chance Of Distress | 360 Days Economic Sensitivity |
Integrated Biopharma OTC Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Integrated daily returns, and it is calculated using variance and standard deviation. We also use Integrated's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Integrated Biopharma volatility.
Integrated |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Integrated Biopharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Integrated Biopharma at lower prices. For example, an investor can purchase Integrated stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Integrated Biopharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.
Moving against Integrated OTC Stock
| 0.57 | BRCNF | Burcon NutraScience Corp | PairCorr |
| 0.55 | LSF | Laird Superfood | PairCorr |
| 0.53 | FRPT | Freshpet | PairCorr |
| 0.44 | LW | Lamb Weston Holdings | PairCorr |
| 0.37 | DAR | Darling Ingredients | PairCorr |
| 0.36 | HLF | Herbalife Nutrition | PairCorr |
Integrated Biopharma Market Sensitivity And Downside Risk
Integrated Biopharma's beta coefficient measures the volatility of Integrated otc stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Integrated otc stock's returns against your selected market. In other words, Integrated Biopharma's beta of -0.31 provides an investor with an approximation of how much risk Integrated Biopharma otc stock can potentially add to one of your existing portfolios. Integrated Biopharma exhibits very low volatility with skewness of 0.5 and kurtosis of 11.85. Integrated Biopharma is a potential penny stock. Although Integrated Biopharma may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Integrated Biopharma. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Integrated instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
3 Months Beta |Analyze Integrated Biopharma Demand TrendCheck current 90 days Integrated Biopharma correlation with market (Dow Jones Industrial)Integrated Beta |
Integrated standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 0.0 |
It is essential to understand the difference between upside risk (as represented by Integrated Biopharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Integrated Biopharma's daily returns or price. Since the actual investment returns on holding a position in integrated otc stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Integrated Biopharma.
Integrated Biopharma OTC Stock Volatility Analysis
Volatility refers to the frequency at which Integrated Biopharma otc price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Integrated Biopharma's price changes. Investors will then calculate the volatility of Integrated Biopharma's otc stock to predict their future moves. A otc that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A otc stock with relatively stable price changes has low volatility. A highly volatile otc is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Integrated Biopharma's volatility:
Historical Volatility
This type of otc volatility measures Integrated Biopharma's fluctuations based on previous trends. It's commonly used to predict Integrated Biopharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the otc stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Integrated Biopharma's current market price. This means that the otc will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Integrated Biopharma's to be redeemed at a future date.Transformation |
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Integrated Biopharma Projected Return Density Against Market
Given the investment horizon of 90 days Integrated Biopharma has a beta of -0.3097 . This usually indicates as returns on the benchmark increase, returns on holding Integrated Biopharma are expected to decrease at a much lower rate. During a bear market, however, Integrated Biopharma is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Integrated Biopharma or Personal Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Integrated Biopharma's price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Integrated otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Integrated Biopharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives an Integrated Biopharma Price Volatility?
Several factors can influence a otc's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Integrated Biopharma OTC Stock Return Volatility
Integrated Biopharma historical daily return volatility represents how much of Integrated Biopharma otc's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The enterprise inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7522% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Integrated Biopharma Volatility
Volatility is a rate at which the price of Integrated Biopharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Integrated Biopharma may increase or decrease. In other words, similar to Integrated's beta indicator, it measures the risk of Integrated Biopharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Integrated Biopharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.
Integrated Biopharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Integrated OTC Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Integrated Biopharma's price varies over time.
3 ways to utilize Integrated Biopharma's volatility to invest better
Higher Integrated Biopharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Integrated Biopharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Integrated Biopharma stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Integrated Biopharma investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Integrated Biopharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Integrated Biopharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Integrated Biopharma Investment Opportunity
Dow Jones Industrial has a standard deviation of returns of 0.75 and is 9.223372036854776E16 times more volatile than Integrated Biopharma. 0 percent of all equities and portfolios are less risky than Integrated Biopharma. You can use Integrated Biopharma to protect your portfolios against small market fluctuations. The otc stock experiences a normal downward fluctuation but is a risky buy. Check odds of Integrated Biopharma to be traded at $0.3267 in 90 days.Good diversification
The correlation between Integrated Biopharma and DJI is -0.06 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and DJI in the same portfolio, assuming nothing else is changed.
Integrated Biopharma Additional Risk Indicators
The analysis of Integrated Biopharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Integrated Biopharma's investment and either accepting that risk or mitigating it. Along with some common measures of Integrated Biopharma otc stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | 0.4707 | |||
| Mean Deviation | 1.52 | |||
| Coefficient Of Variation | (3,056) | |||
| Standard Deviation | 4.05 | |||
| Variance | 16.44 | |||
| Information Ratio | (0.06) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential otc stocks, we recommend comparing similar otcs with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Integrated Biopharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Integrated Biopharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Integrated Biopharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Integrated Biopharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Integrated Biopharma.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |